| Product Code: ETC319646 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for colistin, an antibiotic, may face challenges due to concerns about antibiotic resistance and strict regulations on its use in animal agriculture. The market outlook may depend on shifts in healthcare practices and regulatory changes aimed at reducing the use of colistin in animal feed.
Colistin is an antibiotic used in the healthcare sector, particularly in the treatment of severe bacterial infections. Market dynamics for antibiotics like colistin are influenced by factors such as antibiotic resistance, prescribing practices, and regulatory policies. The outlook for the colistin market in Malaysia is expected to remain stable, with demand driven by healthcare needs. However, antibiotic resistance is a global concern, and changes in antibiotic usage guidelines or the emergence of new treatments could impact the market.
The Malaysia colistin market is confronted by challenges, mainly concerning antibiotic resistance and regulatory scrutiny. Colistin is a last-resort antibiotic, and the emergence of resistant strains of bacteria poses a serious threat to its effectiveness. Strict regulations on antibiotic use and growing concerns about antimicrobial resistance have led to limited usage of colistin in both human and veterinary medicine. Market participants must navigate evolving regulations and invest in research for alternative treatments to address these challenges.
Colistin, an antibiotic used in the treatment of bacterial infections, has garnered attention in Malaysia due to concerns about antibiotic resistance. The COVID-19 pandemic has highlighted the importance of effective antibiotic treatments for secondary infections in critically ill patients. The colistin market in Malaysia is likely to witness growth as healthcare institutions focus on improving their antibiotic stewardship programs. However, there is also a growing awareness of the need for responsible antibiotic use to mitigate the development of antibiotic-resistant strains, making regulatory oversight and education essential in this market.
The colistin market in Malaysia has witnessed the presence of pharmaceutical companies such as Antibiotic Pharmaceuticals, MediCare Labs, and PharmaGuard Pharmaceuticals. These organizations have been actively involved in the production and distribution of antibiotics, including colistin.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Colistin Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Colistin Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Colistin Market - Industry Life Cycle |
3.4 Malaysia Colistin Market - Porter's Five Forces |
3.5 Malaysia Colistin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Malaysia Colistin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Malaysia Colistin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multi-drug resistant infections in Malaysia |
4.2.2 Growing awareness about the importance of antibiotic stewardship programs |
4.2.3 Rising investment in healthcare infrastructure and facilities in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations and policies related to antibiotic use |
4.3.2 Concerns about the development of resistance to colistin |
4.3.3 High cost associated with the development and production of colistin |
5 Malaysia Colistin Market Trends |
6 Malaysia Colistin Market, By Types |
6.1 Malaysia Colistin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Colistin Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 Malaysia Colistin Market Revenues & Volume, By API, 2021-2031F |
6.1.4 Malaysia Colistin Market Revenues & Volume, By Premix, 2021-2031F |
6.1.5 Malaysia Colistin Market Revenues & Volume, By Others, 2021-2031F |
6.2 Malaysia Colistin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Colistin Market Revenues & Volume, By Pig, 2021-2031F |
6.2.3 Malaysia Colistin Market Revenues & Volume, By Chicken, 2021-2031F |
6.2.4 Malaysia Colistin Market Revenues & Volume, By Other, 2021-2031F |
7 Malaysia Colistin Market Import-Export Trade Statistics |
7.1 Malaysia Colistin Market Export to Major Countries |
7.2 Malaysia Colistin Market Imports from Major Countries |
8 Malaysia Colistin Market Key Performance Indicators |
8.1 Percentage increase in funding allocated to combat antibiotic resistance in Malaysia |
8.2 Number of healthcare facilities implementing antibiotic stewardship programs |
8.3 Rate of adoption of colistin alternatives in healthcare settings |
8.4 Number of research studies published on antibiotic resistance trends in Malaysia |
8.5 Percentage of healthcare professionals trained in appropriate antibiotic prescribing practices in the country |
9 Malaysia Colistin Market - Opportunity Assessment |
9.1 Malaysia Colistin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Malaysia Colistin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Malaysia Colistin Market - Competitive Landscape |
10.1 Malaysia Colistin Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Colistin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |